ERIC PIERMONT/AFP/Getty Images
Sanofi Genzyme’s manufacturing facility at Allston Landing in Boston is laying off 130 employees this week to reduce costs and “simplify our operations,” the company said Wednesday.
“We must be flexible in our operations to remain competitive in a dynamic and challenging healthcare environment,” Ashleigh Koss, spokeswoman for the French parent company, Sanofi SA, said in a statement.
Koss would not say how many workers remain at the facility but said Sanofi has about 5,000 employees in Massachusetts — in Allston, Cambridge, Framingham, Northborough, Waltham, and Westborough. They work in research and development, biomanufacturing, and commercial operations.
The Allston Landing plant will remain a biomanufacturing site, she said.
In 2011, Sanofi bought Cambridge-based Genzyme Corp., which specialized in developing medicines for rare diseases, for more than $20 billion. Genzyme, which was renamed Sanofi Genzyme, essentially became the rare-disease unit of Sanofi, which employs about 100,000 people worldwide.
Last month, Sanofi made a major acquisition, paying $11.6 billion to buy the hemophilia drug maker Bioverativ Inc., of Waltham. Biogen Inc., the largest Massachusetts-based drug maker, spun off Bioverativ as a separate company in 2017.
Gas at $3 a gallon. Mortgage rates nearing 5 percent. It’s starting to look a lot like America before the financial crisis.Continue reading »
No one is a winner in the disarray at UMass Boston, and how to move forward isn’t evident.Continue reading »
When it comes to private equity, at least, the state’s pension fund can brag again about being No. 1.Continue reading »
Serious scientists, who’ve long scoffed at “anti-aging” products such as nutritional supplements and growth hormones, are now warming to the idea of slowing human aging.Continue reading »
Private corner offices are out; collaborative bullpens are in. And employers want amenities to attract workers.Continue reading »
The bankrupt Revere candy company is scheduled to be auctioned off Wednesday.Continue reading »
A new mammography system uses a hand-held remote that allows patients to control the level of pressure they feel during the exam.Continue reading »
Video game players eager to improve their skills connect with tutors through the Boston startup Gamer Sensei.Continue reading »
The families of thousands of children who want Spinraza, a newly approved drug for spinal muscular atrophy, have faced numerous hurdles.Continue reading »